7 citations to 10.1016/S0377-2217(99)00427-0 (Crossref Cited-By Service)
  1. Archita Sarmah, Domenico De Giovanni, Pietro De Giovanni, “Compulsory licenses in the pharmaceutical industry: Pricing and R&D strategies”, European Journal of Operational Research, 282, no. 3, 2020, 1053  crossref
  2. Rittwik Chatterjee, Srobonti Chattopadhyay, Tarun Kabiraj, “R&D in a duopoly under incomplete information”, Int J of Economic Theory, 15, no. 4, 2019, 341  crossref
  3. Rittwik Chatterjee, Srobonti Chattopadhyay, Tarun Kabiraj, “R&D Incentives with Uncertain Probability of Success”, Studies in Microeconomics, 2024, 23210222231178578  crossref
  4. Herbert Dawid, Michel Y. Keoula, Michael Kopel, Peter M. Kort, “Dynamic investment strategies and leadership in product innovation”, European Journal of Operational Research, 306, no. 1, 2023, 431  crossref
  5. Chiara Conti, Marco A. Marini, “Are you the right partner? R&D agreement as a screening device”, Economics of Innovation and New Technology, 28, no. 3, 2019, 243  crossref
  6. Luciano Kay, “The effect of inducement prizes on innovation: evidence from theAnsariXPrize and theNorthropGrummanLunarLanderChallenge”, R & D Management, 41, no. 4, 2011, 360  crossref
  7. Maria José Gil-Moltó, Joanna Poyago-Theotoky, José A. Rodrigues-Neto, Vasileios Zikos, “Mixed oligopoly, cost-reducing research and development, and privatisation”, European Journal of Operational Research, 283, no. 3, 2020, 1094  crossref